MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$254,560K
Net Income
-$19,809K
Net Profit Margin
-7.78%
EPS
-$0.31
Unit: Thousand (K) dollars
Revenue Breakdown
US
Non Us
Revenue Breakdown
Supplies And Other
Pump
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Sales
254,560
247,221
290,383
249,253
Cost of sales
109,780
110,433
122,923
114,961
Gross profit
144,780
136,788
167,460
134,292
Selling, general and administrative
111,642
108,187
113,100
108,440
Research and development
46,930
46,035
46,066
48,715
Acquired in-process research and development expenses
0
0
0
0
Litigation and settlement expense
0
-
0
0
Total operating expenses
158,572
154,222
159,166
157,155
Operating gain
-13,792
-17,434
8,294
-22,863
Interest income and other income, net
1,225
3,626
3,016*
2,509
Interest expense
2,450
2,204
2,075
2,065
Loss from equity method investment
-5,641
-3,865
-4,553
-2,724
Loss on extinguishment of debt
-
-
0*
0
Total other income (expense), net
-6,866
-2,443
-3,612
-2,280
Gain before income taxes
-20,658
-19,900
4,639
-25,100
Income tax expense (benefit)
510
516
5,293
-4,000
Net loss
-21,168
-20,393
-589
-21,165
Unrealized gain (loss) on short-term investments
-692
-1,027
-88*
241
Unrealized gain (loss) on cash flow hedges
716
1,702
-195*
534
Foreign currency translation gains
1,335
-1,224
708
648
Comprehensive loss
-19,809
-20,942
-164
-19,742
Basic EPS
-0.31
-0.3
-0.002
-0.31
Diluted EPS
-0.31
-0.3
-0.002
-0.31
Basic Average Shares
69,011,000
68,397,000
68,034,000
67,652,000
Diluted Average Shares
69,011,000
68,397,000
68,034,000
67,652,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Comprehensive loss
-$19,809K
(59.35%↑ Y/Y)
Foreign currency
translation gains
$1,335K
(-69.52%↓ Y/Y)
Unrealized gain (loss) on
cash flow hedges
$716K
(216.99%↑ Y/Y)
Net loss
-$21,168K
(59.60%↑ Y/Y)
Unrealized gain (loss) on
short-term investments
-$692K
(-606.12%↓ Y/Y)
US
$179,292K
(5.34%↑ Y/Y)
Non Us
$75,268K
(6.81%↑ Y/Y)
Gain before income
taxes
-$20,658K
(64.21%↑ Y/Y)
Income tax expense
(benefit)
$510K
(109.58%↑ Y/Y)
Sales
$254,560K
(5.77%↑ Y/Y)
Operating gain
-$13,792K
(73.38%↑ Y/Y)
Total other income
(expense), net
-$6,866K
(-16.14%↓ Y/Y)
Gross profit
$144,780K
(15.04%↑ Y/Y)
Interest income and other
income, net
$1,225K
(293.83%↑ Y/Y)
Cost of sales
$109,780K
(-4.39%↓ Y/Y)
Total operating
expenses
$158,572K
(-10.75%↓ Y/Y)
Loss from equity
method investment
-$5,641K
(-67.14%↓ Y/Y)
Interest expense
$2,450K
(28.61%↑ Y/Y)
Selling, general and
administrative
$111,642K
(1.87%↑ Y/Y)
Research and development
$46,930K
(-2.47%↓ Y/Y)
Buy us a coffee
TANDEM DIABETES CARE INC (TNDM)
TANDEM DIABETES CARE INC (TNDM)